Overview

Neoadjuvant Chemotherapy for Locally Advanced Thymic Cancer

Status:
Completed
Trial end date:
2016-03-01
Target enrollment:
Participant gender:
Summary
We try to evaluate whether neoadjuvant docetaxel plus cisplatin can increase the complete resection rate in advanced thymic carcinoma.
Phase:
Phase 2
Details
Lead Sponsor:
Samsung Medical Center
Treatments:
Cisplatin
Docetaxel